Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2000
12/07/2000CA2374175A1 Compounds and methods for the treatment of post traumatic stress disorder
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2374129A1 Therapeutic use of melatonin
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2373210A1 Fused polycyclic amino acids as pharmaceutical agents
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000CA2371395A1 Amino heterocycles useful as pharmaceutical agents
12/07/2000CA2371089A1 3-heteroarylalkyl substituted gaba analogs
12/07/2000CA2370311A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2339131A1 Nucleic acid molecules with specific recognition of native prpsc, production and use
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1057820A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists
12/06/2000EP1057482A1 Remedy for meniere disease
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056856A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056849A1 Human smn-like protein
12/06/2000EP1056848A1 Human protein kinase c inhibitor
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056748A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056747A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056746A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056745A2 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
12/06/2000EP1056744A1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
12/06/2000EP1056743A1 Benzamine derivatives
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
12/06/2000EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000EP1056705A1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease
12/06/2000EP1056475A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
12/06/2000EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/06/2000EP1056460A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1056448A1 Pharmaceutical combinations containing tramadol
12/06/2000EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275977A Heterocyclic thioesters and ketones
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1275909A In-modulators
12/06/2000CN1275331A Higher unsaturated fatty acid composition
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/06/2000CN1059119C Traditional Chinese medicine for treating various headache and preparation process thereof
12/06/2000CN1059106C Medicine for treating headache and preparation process thereof
12/06/2000CN1059094C Epilepsy pill and producing process thereof
12/05/2000US6156794 Nervous system disorders or alzheimers disease
12/05/2000US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
12/05/2000US6156764 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
12/05/2000US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives
12/05/2000US6156756 Anticoagulants
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156748 Compounds useful as neuro-protective agents
12/05/2000US6156747 Psychological, gastrointestinal, cardiovascular disorders
12/05/2000US6156741 Nervous system disorders
12/05/2000US6156726 Voltage-gated calcium channel antagonist and method
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156291 Chemical and pharmacological standardization of herbal extracts
12/05/2000CA2135179C Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
12/04/2000CA2310873A1 New arylpiperazinylalkyl-3 (2h)-pyridazinones
12/04/2000CA2309395A1 Methods for preventing and treating alzheimer's disease
11/2000
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071534A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
11/30/2000WO2000071533A2 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
11/30/2000WO2000071528A1 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
11/30/2000WO2000071520A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071513A1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071144A1 Prolyl endopeptidase inhibitor
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071134A1 Isophosphoramide mustard analogs and use thereof
11/30/2000WO2000071125A2 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction
11/30/2000WO2000071119A1 Mag expression promoters
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
11/30/2000WO2000071106A2 Method of treating weight gain
11/30/2000WO2000071102A2 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/30/2000WO2000071099A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
1 ... 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 ... 1833